首页> 外文OA文献 >Are three arteries better then two? Impact of using the radial artery in addition to bilateral internal thoracic artery grafting on long term survival
【2h】

Are three arteries better then two? Impact of using the radial artery in addition to bilateral internal thoracic artery grafting on long term survival

机译:三个动脉比两个动脉好吗?除双侧胸内动脉移植外还使用the动脉对长期生存的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

ObjectiveWhether radial artery (RA) as third arterial conduit in addition to bilateral internal thoracic artery (BITA) is associated with better survival than saphenous vein (SV) remains undetermined.MethodsStudy population included a selected low-risk group of 275 subjects undergoing BITA grafting with RA as third arterial conduit (BITA+RA) and 489 undergoing BITA grafting with additional SV graft (BITA+SV). RA was considered only for target stenosis of at least 75%. We finally obtained 275 propensity score–matched pairs for comparison.ResultsOperative mortalities were 1 (0.3%) and 2 (0.7%) for BITA+RA and BITA+SV, respectively (P = .56). After mean follow-up of 10.6 ± 4.8 years, BITA+RA survivals were 97.4% ± 0.9%, 90.3% ± 2.0%, and 81.7% ± 3.2% at 5, 10, and 15 years, respectively, versus 97.0% ± 1.0%, 94.1% ± 1.5%, and 82.1% ± 3.4% (log-rank P = .54; hazard ratio, 1.16; 95% confidence interval, 0.71-1.9). Strategies showed comparable survivals when RA or SV was used to graft the right (P = .79) or left (P = .55) coronary system only. Lack of survival advantage for BITA+RA was confirmed in patients 60 years and younger (P = .80) and older than 60 years (P = .53), with and without diabetes mellitus (P = .89 and P = .54, respectively), and with or without left ventricular dysfunction (P = .95 and P = .65, respectively).ConclusionsLong-term survival in selected low-risk patients undergoing BITA grafting was not extended by using RA as third arterial conduit in preference to SV.
机译:目的除了确定bilateral动脉(RA)作为双侧胸内动脉(BITA)之外的第三大动脉导管是否与隐隐静脉(SV)的存活率更好有关,方法研究人群包括275名接受BITA移植的低危人群RA作为第三动脉导管(BITA + RA),其中489接受了BITA移植,并附加了SV移植物(BITA + SV)。仅将RA用于至少75%的目标狭窄。我们最终获得了275个匹配的倾向得分对进行比较。结果BITA + RA和BITA + SV的手术死亡率分别为1(0.3%)和2(0.7%)(P = .56)。在平均随访10.6±4.8年后,BITA + RA在5、10和15年的存活率分别为97.4%±0.9%,90.3%±2.0%和81.7%±3.2%,而97.0%±1.0 %,94.1%±1.5%和82.1%±3.4%(对数秩P = 0.54;危险比1.16; 95%置信区间0.71-1.9)。当仅使用RA或SV移植右冠状动脉系统(P = .79)或左冠状动脉系统(P = .55)时,策略显示出可比的生存率。在60岁以下(P = .80)和60岁以上(P = .53)的患者中,无论是否患有糖尿病(P = .89和P = .54),都证实了BITA + RA缺乏生存优势。结论:选择低风险患者行BITA移植术的低危患者的长期生存期并未通过使用RA作为第三动脉导管来延长,而未考虑是否存在左心室功能障碍(分别为P = .95和P = .65)。 SV。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号